Endothelial dysfunction markers were linked to future disease activity and complications in lcSSc.

What's new in the management of pulmonary hypertension among ... Cardiopulmonary bypass produces endothelial injury that includes ... With progressive RV dysfunction, pulmonary blood flow ...

A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...

In patients with pulmonary hypertension (PH), high blood pressure occurs in the vessels between the lungs and heart, resulting in increased muscle development in the vessel walls and greater ...

NEW ORLEANS — Sotatercept, a novel activin signaling inhibitor, reduced risk for death and clinical worsening by 84% in patients with pulmonary arterial hypertension compared with placebo ...

Studies have shown that vascular endothelial damage and dysfunction contribute significantly to severe pulmonary outcomes during COVID-19. Furthermore, many extrapulmonary COVID-19 symptoms have ...

Dietary changes may treat pulmonary hypertension Researchers show restricting two amino acids halts disease progression in rodent models Date: May 2, 2024 ...